LCS
ACAD icon

Levin Capital Strategies’s Acadia Pharmaceuticals ACAD Stock Holding History

Levin Capital Strategies’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-17,399
Closed -$485K – 345
2017
Q2 		$485K Sell
17,399
-4,513
-21% -$134K 0.01% 199
2017
Q1 		$753K Buy
+21,912
New +$773K 0.01% 169
2016
Q4 		– Sell
-12,000
Closed -$382 – 304
2016
Q3 		$382 Buy
+12,000
New +$407K 0.01% 250
2016
Q2 		– Sell
-7,904
Closed -$221K – 338
2016
Q1 		$221K Buy
+7,904
New +$172K ﹤0.01% 299
2015
Q3 		– Sell
-5,000
Closed -$209K – 366
2015
Q2 		$209K Sell
5,000
-20,000
-80% -$774K ﹤0.01% 358
2015
Q1 		$815K Buy
+25,000
New +$859K 0.01% 235

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return